Veterinary Medicines Information website

Bimastat Oral Suspension

Authorised
  • NEOMYCIN SULFATE
  • Sulfadiazine
Download as PDF

Product identification

Medicine name:
Bimastat Oral Suspension
Active substance:
  • NEOMYCIN SULFATE
  • Sulfadiazine
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    28.99
    milligram(s)
    /
    1.00
    millilitre(s)
  • Sulfadiazine
    150.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        28
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RA02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • 1 litre white high density polythylene bottles, sealed with a tamper-evident cap containing a pink oralsuspension.
  • 400 ml white high density polythylene bottles, sealed with a tamper-evident cap containing a pink oralsuspension.
  • 250 ml white high density polythylene bottles, sealed with a tamper-evident cap containing a pink oralsuspension.A 50 ml dosing syringe is supplied with the 250 ml presentation only.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bimeda Animal Health Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bimeda Animal Health Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22033/001/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/08/2025
Download